Oncology Pharmacy Residency
The Henry Ford Cancer Institute (HFCI) is one of the largest cancer institutes in the state of Michigan, treating more than 14,000 patients per year and offering multidisciplinary comprehensive cancer care at both the main Henry Ford Hospital campus as well as several of the satellite locations within the Henry Ford Health. The one-year pharmacy residency in Oncology at Henry Ford Hospital has been developed to produce a pharmacy clinical specialist with a robust knowledge of advanced disease-specific content and skills that will allow them to be capable of practicing in a variety of different settings. Residents will work alongside clinical pharmacists in both the ambulatory and inpatient environments allowing for pharmacist mentoring and modeling as well as for integration into the collaborative practice model with close physician and patient interactions.
Purpose: PGY2 pharmacy residency programs build on Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care that improves medication therapy. Residents who successfully complete an accredited PGY2 pharmacy residency should possess competencies that qualify them for clinical pharmacist and/or faculty positions and position them to be eligible for attainment of board certification in the specialized practice area (when board certification for the practice area exists).
The PGY2 residency program is a 12-month learning experience with 2 positions available per year.
Residents will complete thirteen four week rotations including an orientation block in July.
- Orientation (4 weeks)
- Ambulatory hematology/oncology (12 weeks)
- Inpatient hematology/oncology (12 weeks)
- Bone marrow transplantation (8 weeks)
- Oral chemotherapy management (4 weeks and longitudinal responsibility)
- Investigational drugs (4 weeks)
- Oncology Administration and Policy (Longitudinal)
- Benign hematology/hematology consult (4 weeks)
Elective rotations (Resident may elect to repeat primary rotations or choose up to 2 electives):
- Infectious disease
- Information technology
- Palliative medicine
- Participation in pharmacy resident on-call program.
- Participation in staffing of inpatient chemotherapy areas every third weekend.
- Residents are provided opportunities to teach, including didactics, small group facilitation, and clerkship precepting. An elective teaching certificate program is available in collaboration with Wayne State University.
- Residents will be required to complete a major residency project within the year, including preparation and presentation of results at HOPA and preparation and submission of manuscript.
- Residents will participate in weekly Grand Rounds sessions with other pharmacy residents and students as well as formalized oncology-focused didactic sessions.
- Presentation of an oncology-focused continuing education presentation during the year.
Residents receive a competitive stipend with benefits (health insurance, paid time off, parking, professional travel reimbursement, BLS/ACLS certification, shared office and computer access.
Applicants must be graduates of an ACPE-accredited College of Pharmacy have completed an ASHP-accredited PGY1 Pharmacy Practice residency and be eligible for Michigan licensure. Academic transcripts, letter of intent/personal statement, three professional references and curriculum vitae should be submitted to PHORCAS. The application deadline is January 1st. On-site interviews are required.
Angela G. German, PharmD, BCOP
Henry Ford Hospital
2799 W. Grand Boulevard
Detroit, MI 48202
Phone: (313) 916-0032
Fax: (313) 916-1302
Email: [email protected]